| Secondary |
| Acute Graft Versus Host Disease |
21.9% |
| Epstein-barr Virus Associated Lymphoproliferative Disorder |
18.8% |
| Stem Cell Transplant |
12.5% |
| Allogenic Bone Marrow Transplantation Therapy |
6.3% |
| Liver Transplant |
6.3% |
| Anaemia Haemolytic Autoimmune |
3.1% |
| Bladder Dysfunction |
3.1% |
| Depression |
3.1% |
| Headache |
3.1% |
| Immunosuppressant Drug Therapy |
3.1% |
| Lupus Nephritis |
3.1% |
| Muscle Contracture |
3.1% |
| Pulmonary Alveolar Haemorrhage |
3.1% |
| Renal Transplant |
3.1% |
| Systemic Lupus Erythematosus |
3.1% |
| Upper Respiratory Tract Infection |
3.1% |
|
| Cerebral Haemorrhage |
12.5% |
| Cytomegalovirus Infection |
12.5% |
| Endometrial Cancer |
12.5% |
| Large Intestinal Ulcer |
12.5% |
| Nephropathy Toxic |
12.5% |
| Pseudomonal Sepsis |
12.5% |
| Pulmonary Toxicity |
12.5% |
| Weight Increased |
12.5% |
|
| Concomitant |
| Nuclear Magnetic Resonance Imaging |
13.4% |
| Product Used For Unknown Indication |
11.9% |
| Imaging Procedure |
11.5% |
| Angiogram |
6.7% |
| Renal Transplant |
6.5% |
| Restless Legs Syndrome |
5.5% |
| Drug Use For Unknown Indication |
5.3% |
| Thrombosis Prophylaxis |
4.9% |
| Anaemia |
4.2% |
| Nuclear Magnetic Resonance Imaging Brain |
3.8% |
| Organ Transplant |
3.6% |
| Immunosuppressant Drug Therapy |
3.4% |
| Prophylaxis |
3.2% |
| Prophylaxis Against Transplant Rejection |
2.6% |
| Hormone Replacement Therapy |
2.4% |
| Hypotension |
2.4% |
| Hypothyroidism |
2.4% |
| Supplementation Therapy |
2.4% |
| Peritoneal Dialysis |
2.2% |
| Infection |
2.0% |
|
| Pregnancy |
29.8% |
| Tachycardia |
11.5% |
| Nephrogenic Systemic Fibrosis |
5.8% |
| Vomiting |
5.8% |
| Oedema Peripheral |
4.8% |
| Pyrexia |
4.8% |
| Peau D'orange |
3.8% |
| Proteinuria |
3.8% |
| Anxiety |
2.9% |
| Myocardial Infarction |
2.9% |
| Pain In Extremity |
2.9% |
| Pancytopenia |
2.9% |
| Scar |
2.9% |
| Somnolence |
2.9% |
| Thrombosis In Device |
2.9% |
| Blood Pressure Decreased |
1.9% |
| Discomfort |
1.9% |
| Immunosuppressant Drug Level Increased |
1.9% |
| Multi-organ Failure |
1.9% |
| Multiple Sclerosis Relapse |
1.9% |
|
| Interacting |
| Sarcoidosis |
55.6% |
| Immunosuppression |
22.2% |
| Immunosuppressant Drug Therapy |
11.1% |
| Smoking Cessation Therapy |
11.1% |
|
| Alanine Aminotransferase Increased |
50.0% |
| Vomiting |
50.0% |
|
